Curium Pharma has completed its acquisition of Eczacıbaşı-Monrol Nuclear Products Co., enhancing its capacity in nuclear ...

Mike Patterson, Curium’s North American Chief Executive Officer said: “Customers are looking to simplify their business. Our generic version of DTPA allows Curium to offer a more comprehensive list of ...

Positions Curium as leading manufacturer of Lu-177 isotope Brings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT ...

Curium Pharma, a developer, manufacturer, and distributor of nuclear medicine, has acquired Eczacıbaşı-Monrol Nuclear ...

Curium ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc ...

PARIS, March 28, 2025 (GLOBE NEWSWIRE) -- Curium Pharma (“Curium”), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear ...

Positions Curium as leading manufacturer of Lu-177 isotope Brings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT & PET geographical coverage and supply chain PARIS, March 28, ...

We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team. The acquisition enhances Curium’s manufacturing capacity of Lutetium-177 ...

Positions Curium as leading manufacturer of Lu-177 isotope Brings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT & PET geographical coverage and supply chain PARIS ...

PARIS, March 28, 2025 (GLOBE NEWSWIRE) -- Curium Pharma ("Curium”), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear Products ...

That in itself makes it extremely cool. Curium, named after the double Nobel laureate Marie Curie and her husband Pierre, was discovered in 1944 by a scientist called Glenn Seabourg (along with ...